logo
  • Home
  • News
Menu

GC Pharma Announces GreenGene F Approval in China for the Treatment of Haemophilia A

Home / Stock Analysis / GC Pharma Announces GreenGene F Approval in China for the Treatment of Haemophilia A
Article feature image

GC Pharma Announces GreenGene F Approval in China for the Treatment of Haemophilia A

12 Aug Stock Analysis

YONGIN, South Korea–(BUSINESS WIRE)–GC Pharma (006280.KS) today announced the approval of GreenGene F (Beroctocog alfa)

Click here to view the original article.

Tags:
Business Wire, Global
Facebook Google+ Twitter Pinterest
  Previous
Next  

Related Posts

EconomiesOG.png
+

CrowdStrike price gathers positive momentum – Forecast today

01 Jul Stock Analysis
VEE-CA_LONG_lineChartGenerator_2025-06-30_23-32-30.png
+

(VEE) Trading Strategy and Analysis

30 Jun Stock Analysis

recent post

  • EconomiesOG.png

    CrowdStrike price gathers positive momentum –

    Jul 01 2025
  • Crypto Losses Surge 125% in 2025

    Jul 01 2025
  • ChatGPT-Image-Jun-30-2025-02_41_13-PM.png

    Crypto Reserve In The Works: Kazakhstan’s

    Jun 30 2025
  • VEE-CA_LONG_lineChartGenerator_2025-06-30_23-32-30.png

    (VEE) Trading Strategy and Analysis

    Jun 30 2025
  • bank-dollar-pilfer.jpg

    Crypto Products See 11-Week Green Streak

    Jun 30 2025

Categories

  • Business
  • Crypto News
  • Investing Strategy
  • People
  • Stock Analysis

©2019.  All Rights Reserved.